Description
PRINCIPIO ACTIVO: SERRATIOPEPTIDASA
Tratamiento de episodios hemorrágicos en pacientes con hemofilia A o B con inhibidores
METRONIDAZOL 500
SUSTANCIA: REUMOPHAN VIT TAB
CLORHIDRATO DE TRAMADOL 200
OMEPRAZOL INY 40 MG FCO AMP CLIOF. Y AMP C10 ML CIMICIFUGA RACEMOSA PRINCIPIO ACTIVO: SERRATIOPEPTIDASAPRINCIPIO ACTIVO: OMEPRAZOL
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
